SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-17-008642
Filing Date
2017-08-14
Accepted
2017-08-14 15:59:42
Documents
68
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0617_yewbiopharm.htm 10-Q 783506
2 CERTIFICATION f10q0617ex31i_yewbiopharm.htm EX-31.1 10023
3 CERTIFICATION f10q0617ex31ii_yewbiopharm.htm EX-31.2 9997
4 CERTIFICATION f10q0617ex32_yewbiopharm.htm EX-32 4974
  Complete submission text file 0001213900-17-008642.txt   4320055

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE yewb-20170630.xml EX-101.INS 762376
6 XBRL SCHEMA FILE yewb-20170630.xsd EX-101.SCH 57214
7 XBRL CALCULATION FILE yewb-20170630_cal.xml EX-101.CAL 46899
8 XBRL DEFINITION FILE yewb-20170630_def.xml EX-101.DEF 134553
9 XBRL LABEL FILE yewb-20170630_lab.xml EX-101.LAB 457996
10 XBRL PRESENTATION FILE yewb-20170630_pre.xml EX-101.PRE 287017
Mailing Address 294 POWERBILT AVENUE LAS VEGAS NV 89148
Business Address 294 POWERBILT AVENUE LAS VEGAS NV 89148 86-0451-82292379
Yew Bio-Pharm Group, Inc. (Filer) CIK: 0001548240 (see all company filings)

IRS No.: 261579105 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54701 | Film No.: 171029968
SIC: 0100 Agricultural Production-Crops